Massimo Gadina Selected Research

Traction

12/2017

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Massimo Gadina Research Topics

Disease

13	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2006
13	Inflammation (Inflammations) 12/2020 - 06/2007
9	Rheumatoid Arthritis 01/2022 - 02/2004
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 12/2011
6	Neoplasms (Cancer) 01/2019 - 08/2002
3	COVID-19 12/2021 - 01/2020
3	Skin Diseases (Skin Disease) 01/2018 - 01/2014
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2017 - 01/2012
2	VEXAS syndrome 10/2021 - 12/2020
2	Fever (Fevers) 04/2021 - 01/2020
2	Nephritis 01/2021 - 01/2017
2	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2017
2	Lipodystrophy 01/2018 - 11/2015
2	Chronic Disease (Chronic Diseases) 01/2018 - 11/2015
2	Cryopyrin-Associated Periodic Syndromes 01/2017 - 12/2011
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Macrocytic Anemia 10/2021
1	Multiple Myeloma 10/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Chronic Granulomatous Disease 04/2021
1	Headache (Headaches) 04/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Atherosclerosis 01/2021
1	Hyperglycemia 01/2021
1	Proteinuria 01/2021
1	Axial Spondyloarthritis 01/2021
1	Glomerulonephritis 01/2021
1	Erythema 01/2021
1	Hepatitis 07/2020
1	Macrophage Activation Syndrome 07/2020
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2020
1	Lung Diseases (Lung Disease) 07/2020
1	Cytokine Release Syndrome 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Eosinophilia 01/2020
1	Uveitis 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Bites and Stings (Sting) 01/2020
1	Lymphadenopathy 01/2020
1	Chronic Hepatitis C 01/2018
1	Necrosis 01/2018
1	Aseptic Meningitis 01/2017
1	Chromosomal Instability (Chromosome Stability) 10/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2014

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2021 - 02/2004
11	Janus Kinase InhibitorsIBA 01/2022 - 01/2012
11	tofacitinibIBA 01/2022 - 04/2011
6	Phosphotransferases (Kinase)IBA 01/2020 - 06/2004
5	Janus KinasesIBA 01/2021 - 12/2013
5	Interleukin-1 (Interleukin 1)IBA 07/2020 - 06/2007
4	AutoantibodiesIBA 01/2020 - 06/2009
3	baricitinibIBA 01/2022 - 01/2018
3	Biological ProductsIBA 01/2021 - 12/2016
3	InterferonsIBA 01/2020 - 09/2002
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2002
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2021 - 12/2011
2	EnzymesIBA 10/2021 - 12/2020
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 07/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 09/2002
2	Cytokine Receptors (Cytokine Receptor)IBA 12/2016 - 01/2006
2	Adenosine DeaminaseIBA 03/2014 - 10/2006
2	Interleukin-33IBA 06/2007 - 01/2006
2	NF-kappa B (NF-kB)IBA 06/2004 - 02/2004
1	GLPG0634IBA 01/2022
1	peficitinibIBA 01/2022
1	upadacitinibIBA 01/2022
1	SteroidsIBA 04/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	AntibodiesIBA 04/2021
1	Ferritins (Ferritin)IBA 04/2021
1	NitrogenIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Histocompatibility Antigens Class IIIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	CaspasesIBA 01/2020
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020
1	Tumor Necrosis Factor InhibitorsIBA 01/2018
1	InterleukinsIBA 01/2018
1	canakinumab FDA Link 01/2017
1	Complement C1r (Complement Component 1r)IBA 01/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017
1	Interleukin-18 (Interleukin 18)IBA 01/2017
1	CohesinsIBA 10/2016
1	Bromodeoxyuridine (BrdU)IBA 10/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2015

Therapy/Procedure

4	Therapeutics 07/2020 - 12/2011
2	Biological Therapy 01/2021 - 12/2016
1	Blood Transfusion (Blood Transfusions) 01/2018
1	Traction 12/2017
1	Aftercare (After-Treatment) 01/2017
1	Hematopoietic Stem Cell Transplantation 04/2014